The p.W159* mutation identified in a patient with CCA within the present study appears to play a role in the targeting of the Wnt receptor frizzled for ubiquitination and in the removal of RNF43 from the cell surface with a consequent increase in Wnt activity [54]. This evidence concerns the gene RNF43 and cholangiocarcinoma.